Histamine receptors in GtoPdb v.2021.3

Histamine receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Histamine Receptors [80, 173]) are activated by the endogenous ligand histamine. Marked species differences exist between histamine receptor orthologues [80]. The human and rat H3 receptor genes are subject to significant splice variance [12]. The potency order of histamine at histamine receptor subtypes is H3 = H4 > H2 > H1 [173]. Some agonists at the human H3 receptor display significant ligand bias [182]. Antagonists of all 4 histamine receptors have clinical uses: H1 antagonists for allergies (e.g. cetirizine), H2 antagonists for acid-reflux diseases (e.g. ranitidine), H3 antagonists for narcolepsy (e.g. pitolisant/WAKIX; Registered) and H4 antagonists for atopic dermatitis (e.g. adriforant; Phase IIa) [173] and vestibular neuritis (AUV) (SENS-111 (Seliforant, previously UR-63325), entered and completed vestibular neuritis (AUV) Phase IIa efficacy and safety trials, respectively) [216, 8].

[1]  H. Stark,et al.  Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis , 2021, Neuropharmacology.

[2]  S. Chaki,et al.  A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, and Wake-Promoting and Procognitive Effects in Rodents , 2020, The Journal of Pharmacology and Experimental Therapeutics.

[3]  Peter Buneman,et al.  Why data citation isn't working, and what to do about it , 2020, Database J. Biol. Databases Curation.

[4]  J. Dyhrfjeld-Johnsen,et al.  Effect of the novel histamine H4 receptor antagonist SENS‐111 on spontaneous nystagmus in a rat model of acute unilateral vestibular loss , 2019, British journal of pharmacology.

[5]  I. Osterloh,et al.  Efficacy and safety of the histamine H4 receptor antagonist ZPL‐3893787 in patients with atopic dermatitis , 2019, The Journal of allergy and clinical immunology.

[6]  S. Schmerber,et al.  Safety, tolerability, pharmacokinetics and pharmacokinetic‐pharmacodynamic modelling of the novel H4 receptor inhibitor SENS‐111 using a modified caloric test in healthy subjects , 2018, British journal of clinical pharmacology.

[7]  E. Park,et al.  Discovery of a Novel Highly Selective Histamine H4 Receptor Antagonist for the Treatment of Atopic Dermatitis. , 2018, Journal of medicinal chemistry.

[8]  Rob Leurs,et al.  Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology , 2018, Journal of the American Chemical Society.

[9]  C. Langmead,et al.  Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists , 2017, Molecular Pharmacology.

[10]  Francesca Levi-Schaffer,et al.  Mast cell and eosinophil surface receptors as targets for anti‐allergic therapy , 2017, Pharmacology & therapeutics.

[11]  R. Gomeni,et al.  The Effects of SENS-111, A New H4R Antagonist, On Vertigo Induced by Caloric Test in Healthy Volunteers (HV) is Related to Plasma Concentrations. , 2016, Clinical therapeutics.

[12]  Rob Leurs,et al.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors , 2015, Pharmacological Reviews.

[13]  R. Seifert,et al.  The histamine H4‐receptor (H4R) regulates eosinophilic inflammation in ovalbumin‐induced experimental allergic asthma in mice , 2015, European journal of immunology.

[14]  R. Thurmond.  The histamine H4 receptor: from orphan to the clinic , 2015, Front. Pharmacol..

[15]  A. Prema,et al.  Functional characterization of histamine H4 receptor on human mast cells. , 2014, Molecular immunology.

[16]  H. Stark,et al.  Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs. , 2014, European journal of medicinal chemistry.

[17]  R. Thurmond,et al.  Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists. , 2014, Journal of medicinal chemistry.

[18]  Simone Brogi,et al.  Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds. , 2013, European journal of medicinal chemistry.

[19]  B. Springthorpe,et al.  The discovery of CCR3/H1 dual antagonists with reduced hERG risk. , 2012, Bioorganic & medicinal chemistry letters.

[20]  F. Levi-Schaffer,et al.  Novel Identified Receptors on Mast Cells , 2012, Front. Immun..

[21]  Jiri Aubrecht,et al.  Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764). , 2011, Journal of medicinal chemistry.

[22]  Ruben Abagyan,et al.  Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.

[23]  M. Tobe,et al.  Synthesis and structure-activity relationship of tricyclic carboxylic acids as novel anti-histamines. , 2011, Bioorganic & medicinal chemistry.

[24]  Kenneth L. Clark,et al.  The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis. , 2011, Journal of medicinal chemistry.

[25]  Michael Berlin,et al.  Histamine H3 receptor as a drug discovery target. , 2011, Journal of medicinal chemistry.

[26]  Xiaohong Zhu,et al.  Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs. , 2009, Bioorganic & medicinal chemistry letters.

[27]  Siobhan Malany,et al.  Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia. , 2009, Bioorganic & Medicinal Chemistry Letters.

[28]  E. Tiligada,et al.  The role of histamine H4 receptor in immune and inflammatory disorders , 2009, British journal of pharmacology.

[29]  H. Stark,et al.  Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands. , 2009, Bioorganic & medicinal chemistry.

[30]  H. Stark,et al.  Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics. , 2009, Bioorganic & medicinal chemistry letters.

[31]  M. Nettekoven,et al.  Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists. , 2008, Bioorganic & medicinal chemistry letters.

[32]  R. Yoshimoto,et al.  Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists. , 2008, Journal of medicinal chemistry.

[33]  R. Leurs,et al.  Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. , 2007, The Journal of allergy and clinical immunology.

[34]  Michael A. Briggs,et al.  GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer's Disease Brain and Improves Cognitive Performance in Preclinical Models , 2007, Journal of Pharmacology and Experimental Therapeutics.

[35]  F. Rice,et al.  Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: Potential antinociceptive targets , 2007, Pain.

[36]  R. Smits,et al.  Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. , 2006, Journal of medicinal chemistry.

[37]  Alexander Golbraikh,et al.  Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes. , 2006, Bioorganic & medicinal chemistry.

[38]  F. Zhou,et al.  Opposite functions of histamine H1 and H2 receptors and H3 receptor in substantia nigra pars reticulata. , 2006, Journal of neurophysiology.

[39]  K. Sansuk,et al.  Oligomerization of Recombinant and Endogenously Expressed Human Histamine H4 Receptors , 2006, Molecular Pharmacology.

[40]  R. Smits,et al.  Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives. , 2006, Journal of medicinal chemistry.

[41]  Rob Leurs,et al.  Discovery of Naturally Occurring Splice Variants of the Rat Histamine H3 Receptor That Act as Dominant-Negative Isoforms , 2006, Molecular Pharmacology.

[42]  R. Seifert,et al.  Probing Ligand-Specific Histamine H1- and H2-Receptor Conformations with NG-Acylated Imidazolylpropylguanidines , 2006, Journal of Pharmacology and Experimental Therapeutics.

[43]  J. Arrang,et al.  Compared pharmacology of human histamine H3 and H4 receptors: structure–activity relationships of histamine derivatives , 2006, British journal of pharmacology.

[44]  L. Renaud,et al.  Histamine excites neonatal rat sympathetic preganglionic neurons in vitro via activation of H1 receptors. , 2006, Journal of neurophysiology.

[45]  M. Matsubara,et al.  Histamine H1 Receptor-Stimulated Interleukin 8 and Granulocyte Macrophage Colony-Stimulating Factor Production by Bronchial Epithelial Cells Requires Extracellular Signal-Regulated Kinase Signaling via Protein Kinase C , 2006, International Archives of Allergy and Immunology.

[46]  H. Kawasaki,et al.  Histamine-induced vasodilation and vasoconstriction in the mesenteric resistance artery of the rat. , 2006, European journal of pharmacology.

[47]  C. Ganellin,et al.  Histamine and its receptors , 2006, British journal of pharmacology.

[48]  H. H. Refsgaard,et al.  Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight , 2005, International Journal of Obesity.

[49]  M. Manns,et al.  Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract , 2005, Gut.

[50]  Kazuhiro Takahashi,et al.  Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice , 2005, Pain.

[51]  Motohisa Kato,et al.  Blockage of histamine H1 receptor attenuates social isolation-induced disruption of prepulse inhibition: a study in H1 receptor gene knockout mice , 2005, Psychopharmacology.

[52]  Naotoshi Sugimoto,et al.  Involvement of the βγ subunits of G proteins in the cAMP response induced by stimulation of the histamine H1 receptor , 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

[53]  R. Morphy,et al.  Designed multiple ligands. An emerging drug discovery paradigm. , 2005, Journal of medicinal chemistry.

[54]  R. Thurmond,et al.  The histamine H4 receptor as a new therapeutic target for inflammation. , 2005, Trends in pharmacological sciences.

[55]  Rob Leurs,et al.  Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist , 2005, Journal of Pharmacology and Experimental Therapeutics.

[56]  H. Yoshimatsu,et al.  The role of histamine H1 receptor and H2 receptor in LPS‐induced liver injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  Thomas R. Miller,et al.  Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties , 2005, Journal of Pharmacology and Experimental Therapeutics.

[58]  A. Megens,et al.  Norpiperidine imidazoazepines as a new class of potent, selective, and nonsedative H1 antihistamines. , 2005, Journal of medicinal chemistry.

[59]  I. D. de Esch,et al.  N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist. , 2005, Journal of medicinal chemistry.

[60]  K. Cannon,et al.  Inhibition of chemical and low-intensity mechanical nociception by activation of histamine H3 receptors. , 2005, The journal of pain : official journal of the American Pain Society.

[61]  K. Yanai,et al.  The anorectic effect of neurotensin is mediated via a histamine H1 receptor in mice , 2004, Peptides.

[62]  T. Lewis,et al.  Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. , 2004, Bioorganic & medicinal chemistry letters.

[63]  R. Thurmond,et al.  Histamine H4 receptor antagonists: the new antihistamines? , 2004, Current opinion in investigational drugs.

[64]  C. Minson,et al.  H1 but not H2 histamine receptor activation contributes to the rise in skin blood flow during whole body heating in humans , 2004, The Journal of physiology.

[65]  I. D. de Esch,et al.  Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists. , 2004, Bioorganic & medicinal chemistry letters.

[66]  S. Cragg,et al.  Histamine H3 Receptors Inhibit Serotonin Release in Substantia Nigra Pars Reticulata , 2004, The Journal of Neuroscience.

[67]  M. Williams,et al.  Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist. , 2004, Biochemical pharmacology.

[68]  H. Yoshimatsu,et al.  Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. , 2004, Diabetes.

[69]  J. Schwartz,et al.  Cloning and expression of the mouse histamine H3 receptor: evidence for multiple isoforms , 2004, Journal of neurochemistry.

[70]  Matthew C. Canver,et al.  Histamine H1 and H2 receptor-mediated vasoreactivity of human internal thoracic and radial arteries. , 2004, Surgery.

[71]  M. Babina,et al.  Human skin mast cells express H2 and H4, but not H3 receptors. , 2004, The Journal of investigative dermatology.

[72]  R. Leurs,et al.  Large-scale overproduction, functional purification and ligand affinities of the His-tagged human histamine H1 receptor. , 2004, European journal of biochemistry.

[73]  F. Gantner,et al.  Critical Role of L-Selectin and Histamine H4 Receptor in Zymosan-Induced Neutrophil Recruitment from the Bone Marrow: Comparison with Carrageenan , 2004, Journal of Pharmacology and Experimental Therapeutics.

[74]  R. Thurmond,et al.  Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation , 2004, British journal of pharmacology.

[75]  N. Matsuda,et al.  Histamine H1 and H2 Receptor Gene and Protein Levels Are Differentially Expressed in the Hearts of Rodents and Humans , 2004, Journal of Pharmacology and Experimental Therapeutics.

[76]  K. Ishii,et al.  Evaluation of in vivo selective binding of [11C]doxepin to histamine H1 receptors in five animal species. , 2004, Nuclear medicine and biology.

[77]  O. Zuiderveld,et al.  Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist. , 2004, Journal of medicinal chemistry.

[78]  J. Raber,et al.  Anxiety and cognition in histamine H3 receptor−/− mice , 2004, The European journal of neuroscience.

[79]  Lars Karlsson,et al.  A Potent and Selective Histamine H4 Receptor Antagonist with Anti-Inflammatory Properties , 2004, Journal of Pharmacology and Experimental Therapeutics.

[80]  E. Bush,et al.  Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. , 2004, European journal of pharmacology.

[81]  K. Nakano,et al.  Regulation of Con A – dependent cytokine production from CD4+ and CD8+ T lymphocytes by autosecretion of histamine , 2004, Inflammation Research.

[82]  K. Ishii,et al.  Quantitative measurement of histamine H(1) receptors in human brains by PET and [11C]doxepin. , 2004, Nuclear medicine and biology.

[83]  J. Hey,et al.  Activation of histamine H3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. , 2004, European journal of pharmacology.

[84]  Paul Ernsberger,et al.  H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs , 2003, Neuropsychopharmacology.

[85]  R. Leurs,et al.  Synthesis and pharmacological identification of neutral histamine H1-receptor antagonists. , 2003, Journal of medicinal chemistry.

[86]  T. Williams,et al.  Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor , 2003, British journal of pharmacology.

[87]  C. Shayo,et al.  Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model. , 2003, Molecular pharmacology.

[88]  J. A. Jablonowski,et al.  The first potent and selective non-imidazole human histamine H4 receptor antagonists. , 2003, Journal of medicinal chemistry.

[89]  C. Dvorak,et al.  A new class of diamine-based human histamine H3 receptor antagonists: 4-(aminoalkoxy)benzylamines. , 2003, Journal of medicinal chemistry.

[90]  R. Stadel,et al.  Activation of spinal histamine H3 receptors inhibits mechanical nociception. , 2003, European journal of pharmacology.

[91]  P. Desai,et al.  Histamine H4 Receptor Mediates Chemotaxis and Calcium Mobilization of Mast Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[92]  T. Bürckstümmer,et al.  Multiple Differences in Agonist and Antagonist Pharmacology between Human and Guinea Pig Histamine H1-Receptor , 2003, Journal of Pharmacology and Experimental Therapeutics.

[93]  Michael Williams,et al.  Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects , 2003, Journal of Pharmacology and Experimental Therapeutics.

[94]  Robert Pearlstein,et al.  Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior. , 2003, Journal of medicinal chemistry.

[95]  T. Lovenberg,et al.  Molecular and pharmacological characterization of the mouse histamine H3 receptor. , 2003, European journal of pharmacology.

[96]  A. Kakigi,et al.  Expression of mRNA encoding the H1, H2, and H3 histamine receptors in the rat cochlea , 2003, Neuroreport.

[97]  T. Lovenberg,et al.  Norepinephrine release from the ischemic heart is greatly enhanced in mice lacking histamine H3 receptors. , 2003, Molecular pharmacology.

[98]  Ernst Mutschler,et al.  Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists. , 2003, Journal of medicinal chemistry.

[99]  H. Kotani,et al.  Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. , 2002, The Journal of clinical investigation.

[100]  E. Borda,et al.  H(1)-Receptor activation triggers the endogenous nitric oxide signalling system in the rat submandibular gland. , 2002, Mediators of inflammation.

[101]  J. Aceves,et al.  Histamine H1 receptors in rat dorsal raphe nucleus: pharmacological characterisation and linking to increased neuronal activity , 2002, Brain Research.

[102]  S. Hastrup,et al.  Characteristics of recombinantly expressed rat and human histamine H3 receptors. , 2002, European journal of pharmacology.

[103]  J. Schwartz,et al.  A detailed mapping of the histamine H3 receptor and its gene transcripts in rat brain , 2002, Neuroscience.

[104]  E. Baldi,et al.  Activation of histaminergic H3 receptors in the rat basolateral amygdala improves expression of fear memory and enhances acetylcholine release , 2002, The European journal of neuroscience.

[105]  W. Graier,et al.  Functional Analysis Of Histamine Receptor Subtypes Involved In Endothelium‐Mediated Relaxation Of The Human Uterine Artery , 2002, Clinical and experimental pharmacology & physiology.

[106]  T. Lovenberg,et al.  Behavioral characterization of mice lacking histamine H(3) receptors. , 2002, Molecular pharmacology.

[107]  F. Monsma,et al.  Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor. , 2002, Molecular pharmacology.

[108]  R. Leurs,et al.  A novel phenylaminotetralin radioligand reveals a subpopulation of histamine H(1) receptors. , 2002, The Journal of pharmacology and experimental therapeutics.

[109]  K. Yanai,et al.  Enhanced antinociception by intrathecally-administered morphine in histamine H1 receptor gene knockout mice , 2002, Neuropharmacology.

[110]  T. Kajiwara,et al.  Effects of N-alpha-methyl-histamine on human H2 receptors expressed in CHO cells , 2002, Gut.

[111]  M. Gillard,et al.  Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). , 2002, Molecular pharmacology.

[112]  M. Trevethick,et al.  IDENTIFICATION OF A HISTAMINE H4 RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS , 2002, Journal of receptor and signal transduction research.

[113]  T. Kajiwara,et al.  Potent and Long-Lasting Action of Lafutidine on the Human Histamine H2 Receptor , 2001, Digestion.

[114]  T. Lovenberg,et al.  Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists. , 2001, The Journal of pharmacology and experimental therapeutics.

[115]  A. Ortega,et al.  Histamine H1 Receptor Activation Stimulates Mitogenesis in Human Astrocytoma U373 MG Cells , 2001, Journal of Neuro-Oncology.

[116]  E. Baldi,et al.  Histamine H3 receptor‐mediated impairment of contextual fear conditioning and in‐vivo inhibition of cholinergic transmission in the rat basolateral amygdala , 2001, The European journal of neuroscience.

[117]  E. Scharrer,et al.  Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[118]  T. Lovenberg,et al.  Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. , 2001, The Journal of pharmacology and experimental therapeutics.

[119]  J. Schwartz,et al.  Expression analysis of the histamine H3 receptor in developing rat tissues , 2001, Mechanisms of Development.

[120]  J. Boutin,et al.  Structure and expression of the human histamine H4-receptor gene. , 2001, Biochemical and biophysical research communications.

[121]  J. Boutin,et al.  Genomic organization and characterization of splice variants of the human histamine H3 receptor. , 2001, The Biochemical journal.

[122]  V. Setola,et al.  Discovery of a novel member of the histamine receptor family. , 2001, Molecular pharmacology.

[123]  F. Monsma,et al.  Cloning and characterization of a novel human histamine receptor. , 2001, The Journal of pharmacology and experimental therapeutics.

[124]  C. M. Davenport,et al.  Cloning, expression, and pharmacological characterization of a novel human histamine receptor. , 2001, Molecular pharmacology.

[125]  Nicholas J. Carruthers,et al.  Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. , 2001, Molecular pharmacology.

[126]  P. Chazot,et al.  Immunological identification of the mammalian H3 histamine receptor in the mouse brain , 2001, Neuroreport.

[127]  H. Yoshimatsu,et al.  Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. , 2001, Diabetes.

[128]  J. Schwartz,et al.  The rat H3 receptor: gene organization and multiple isoforms. , 2001, Biochemical and biophysical research communications.

[129]  K. Tanaka,et al.  Molecular cloning and characterization of a new human histamine receptor, HH4R. , 2000, Biochemical and biophysical research communications.

[130]  T. Watanabe,et al.  Vascular permeability in allergic conjunctivitis in mice lacking histamine H1 receptors. , 2000, European journal of pharmacology.

[131]  C R Ganellin,et al.  Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain , 2000, British journal of pharmacology.

[132]  Y. Masuho,et al.  Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in Leukocytes* , 2000, The Journal of Biological Chemistry.

[133]  R. Leurs,et al.  Characterization of histamine H3 receptors in mouse brain using the H3 antagonist [125I]iodophenpropit , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[134]  Takashi Kobayashi,et al.  Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. , 2000, The Journal of clinical investigation.

[135]  M. Erlander,et al.  Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles. , 2000, The Journal of pharmacology and experimental therapeutics.

[136]  Kumiko Nakamura,et al.  Histamine H(3) receptor-mediated inhibition of endogenous acetylcholine release from the isolated, vascularly perfused rat stomach. , 2000, European journal of pharmacology.

[137]  Takeshi Watanabe,et al.  Involvement of the Histaminergic System in Leptin-Induced Suppression of Food Intake , 1999, Physiology & Behavior.

[138]  C. Sánchez,et al.  Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding , 1999, Cellular and Molecular Neurobiology.

[139]  M. Jackson,et al.  Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.

[140]  R. E. Brown,et al.  On the mechanism of histaminergic inhibition of glutamate release in the rat dentate gyrus , 1999, The Journal of physiology.

[141]  Y. Kiuchi,et al.  Interaction of the New Histamine H2-Receptor Antagonist Pibutidine Hydrochloride with Canine Cloned H2-Receptor Expressed Cells , 1999, Arzneimittelforschung.

[142]  J. Neefs,et al.  Structure of the human histamine H1 receptor gene. , 1998, The Biochemical journal.

[143]  R. Leurs,et al.  Constitutive Activity and Structural Instability of the Wild‐Type Human H2 Receptor , 1998, Journal of neurochemistry.

[144]  T. Watanabe,et al.  Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors , 1998, Neuroscience.

[145]  W. Schunack,et al.  Evidence for hypernociception induction following histamine H1 receptor activation in rodents. , 1998, Life sciences.

[146]  P. Panula,et al.  In situ detection of H1‐receptor mRNA and absence of apoptosis in the transient histamine system of the embryonic rat brain , 1998, The Journal of comparative neurology.

[147]  T. Watanabe,et al.  Targeting disruption of histamine H1 receptors in mice: behavioral and neurochemical characterization. , 1998, Life sciences.

[148]  H. Haas,et al.  Histamine increases the bursting activity of pyramidal cells in the CA3 region of mouse hippocampus , 1998, Neuroscience Letters.

[149]  R. Leurs,et al.  Heterologous expression of rat epitope‐tagged histamine H2 receptors in insect Sf9 cells , 1997, British journal of pharmacology.

[150]  H. Haas,et al.  International Union of Pharmacology. XIII. Classification of histamine receptors. , 1997, Pharmacological reviews.

[151]  J. Olesen,et al.  Role of endothelium and nitric oxide in histamine‐induced responses in human cranial arteries and detection of mRNA encoding H1‐ and H2‐receptors by RT‐PCR , 1997, British journal of pharmacology.

[152]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.

[153]  R. Pearson,et al.  Individuals with schizophrenia have an increased incidence of the H2R649G allele for the histamine H2 receptor gene. , 1996, Molecular psychiatry.

[154]  T. Gudermann,et al.  G proteins of the Gq family couple the H2 histamine receptor to phospholipase C. , 1996, Molecular endocrinology.

[155]  I. Taniuchi,et al.  Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[156]  N. Copeland,et al.  Cloning, RNA expression, and chromosomal location of a mouse histamine H2 receptor gene. , 1996, Genomics.

[157]  N. Copeland,et al.  Characteristics of the mouse genomic histamine H1 receptor gene. , 1996, Genomics.

[158]  R. Leurs,et al.  Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[159]  I. Pang,et al.  Effect of histamine on phosphoinositide turnover and intracellular calcium in human ciliary muscle cells. , 1996, Experimental eye research.

[160]  P. F. M. Janssen,et al.  Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding , 1996, Psychopharmacology.

[161]  A. Mistretta,et al.  Inhaled lysine acetylsalicylate (L‐ASA) attenuates histamine‐induced bronchoconstriction in asthma , 1996, Allergy.

[162]  M. Chiavarini,et al.  R‐α‐methylhistamine‐induced inhibition of gastric acid secretion in pylorus‐ligated rats via central histamine H3 receptors , 1995, British journal of pharmacology.

[163]  J. Schwartz,et al.  The guinea pig histamine H2 receptor: gene cloning, tissue expression and chromosomal localization of its human counterpart. , 1995, Biochemical and biophysical research communications.

[164]  H. Schoemaker,et al.  In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent. , 1995, Arzneimittel-Forschung.

[165]  K. Adler,et al.  Histamine provokes turnover of inositol phospholipids in guinea pig and human airway epithelial cells via an H1-receptor/G protein-dependent mechanism. , 1995, American journal of respiratory cell and molecular biology.

[166]  K. Nishi,et al.  Inhibitory effect of terfenadine, a selective H1 histamine antagonist, on alcoholic beverage-induced bronchoconstriction in asthmatic patients. , 1995, The European respiratory journal.

[167]  R. González,et al.  Increased affinity of histamine H1 binding to membranes of human myometrium at the end of pregnancy. , 1994, General pharmacology.

[168]  A. Bast,et al.  Characterization of the binding of the first selective radiolabeled histamine H3‐receptor antagonist, [125I]‐iodophenpropit, to rat brain , 1994, British journal of pharmacology.

[169]  C. Szpirer,et al.  Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene. , 1994, European journal of biochemistry.

[170]  R. Berger,et al.  Chromosomal localization of the human histamine H1-receptor gene , 1994, Human Genetics.

[171]  R. Leurs,et al.  Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells , 1994, British journal of pharmacology.

[172]  S. Takai,et al.  Molecular cloning of the human histamine H1 receptor gene. , 1994, Biochemical and biophysical research communications.

[173]  R. Levi,et al.  Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels. , 1994, The Journal of pharmacology and experimental therapeutics.

[174]  J. Leysen,et al.  Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. , 1993, Biochemical and biophysical research communications.

[175]  R. Egan,et al.  Guanine nucleotides and pertussis toxin reduce the affinity of histamine H3 receptors on AtT-20 cells , 1993, Agents and Actions.

[176]  Y. Horio,et al.  Genomic cloning of the rat histamine H1 receptor. , 1993, Biochemical and biophysical research communications.

[177]  F. Morales-Olivas,et al.  Effect of histamine and histamine analogues on human isolated myometrial strips , 1992, British journal of pharmacology.

[178]  T. Nonaka,et al.  Histamine-induced differentiation of HL-60 cells. The role of cAMP and protein kinase A. , 1992, Biochemical pharmacology.

[179]  J. Schwartz,et al.  Cloning and tissue expression of a rat histamine H2-receptor gene. , 1991, Biochemical and Biophysical Research Communications - BBRC.

[180]  T. Yamada,et al.  Molecular cloning of the human histamine H2 receptor. , 1991, Biochemical and biophysical research communications.

[181]  S. Hill,et al.  Distribution, properties, and functional characteristics of three classes of histamine receptor. , 1990, Pharmacological reviews.

[182]  L. Tertoolen,et al.  Histamine-H1-receptor-mediated phosphoinositide hydrolysis, Ca2+ signalling and membrane-potential oscillations in human HeLa carcinoma cells. , 1990, The Biochemical journal.

[183]  M. Mitsuhashi,et al.  Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. , 1989, The Journal of biological chemistry.

[184]  J. Black.  Drugs from emasculated hormones: The principle of syntopic antagonism , 1989, In vitro cellular & developmental biology : journal of the Tissue Culture Association.

[185]  H. Yoshimatsu,et al.  Neuronal histamine modulates feeding behavior through H1-receptor in rat hypothalamus. , 1989, The American journal of physiology.

[186]  T. Fan,et al.  Histamine stimulates inositol phosphate accumulation via the H1-receptor in cultured human endothelial cells. , 1987, Biochemical and biophysical research communications.

[187]  U. Haglund,et al.  Histamine H2-receptor of human and rabbit parietal cells. , 1987, The American journal of physiology.

[188]  J. Schwartz,et al.  Highly potent and selective ligands for histamine H3-receptors , 1987, Nature.

[189]  E. O. Alvarez,et al.  Histamine in dorsal and ventral hippocampus. II. Effects of H1 and H2 histamine antagonists on exploratory behavior in male rats , 1986, Physiology & Behavior.

[190]  S. Todorov,et al.  The role of H1- and H2-receptors in the modulatory effects of histaminergic agents on adrenergic neurotransmission in rat vas deferens. , 1986, Methods and findings in experimental and clinical pharmacology.

[191]  R. Schellenberg,et al.  Histamine releases PGI2 from human pulmonary artery. , 1986, Prostaglandins.

[192]  J. Schwartz,et al.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor , 1983, Nature.

[193]  M. Flannery,et al.  Dose-response curve analysis of gastric secretory responses in the dog and man to impromidine: a new histamine-H2-receptor agonist. , 1983, The Journal of pharmacology and experimental therapeutics.

[194]  J. Abita,et al.  Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils. , 1982, Molecular pharmacology.

[195]  L. Fielding,et al.  Gastric acid secretion induced by impromidine in the dog and man: Analysis of dose-response relationships , 1982, Agents and Actions.

[196]  A. Guz,et al.  The role of histamine receptors in asthma. , 1981, Clinical science.

[197]  N. Thomson,et al.  Effect of inhaled H1 and H2 receptor antagonist in normal and asthmatic subjects. , 1980, Thorax.

[198]  T. Yoshino,et al.  An experimental study on histamine H2-receptor antagonist on calcium, gastrin and histamine induced gastric acid secretion in rat , 1979, Gastroenterologia Japonica.

[199]  D. Richards,et al.  Effects of H1- and H2-receptor blocking agents on histamine-induced bronchoconstriction in non-asthmatic subjects. , 1979, British journal of clinical pharmacology.

[200]  H. Petersen,et al.  Stimulation of gastric acid secretion by dimaprit in unanesthetized rats , 1978, Agents and Actions.

[201]  W. Lippmann,et al.  A relatively specific and quantitative assay for histamine H2-receptor blocking activity by determination of inhibition of histamine-induced gastric acid secretion in the rat. , 1978, European journal of pharmacology.

[202]  R. Türker,et al.  Histamine receptors in the isolated rat stomach fundus and rabbit aortic strips. , 1977, Pharmacology.

[203]  R. Evans,et al.  Further studies on the mechanism of human histamine-induced asthma: the effect of an aerosolized H1 receptor antagonist (diphenhydramine). , 1977, The Journal of allergy and clinical immunology.

[204]  K. Bhargava,et al.  NATURE OF HISTAMINE RECEPTORS CONCERNED IN CAPILLARY PERMEABILITY , 1977, British journal of pharmacology.

[205]  B. Whittle,et al.  A study of the vascular and acid‐secretory responses of the rat gastric mucosa to histamine. , 1976, The Journal of physiology.

[206]  J. Black,et al.  Definition and Antagonism of Histamine H2-receptors , 1972, Nature.

[207]  E. Loew.  Pharmacology of antihistamine compounds. , 1947, Physiological reviews.

[208]  S. Hishinuma,et al.  Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization. , 2008, Journal of pharmacological sciences.

[209]  H. Kotani,et al.  Recent advances in molecular pharmacology of the histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders. , 2006, Journal of pharmacological sciences.

[210]  A. Orjales,et al.  Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist , 2005, Drugs in R&D.

[211]  A. Spek,et al.  Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists. , 2003, Journal of medicinal chemistry.

[212]  Takeshi Watanabe,et al.  Utilization of knockout mice to examine the potential role of gastric histamine H2-receptors in Menetrier's disease. , 2003, Journal of pharmacological sciences.

[213]  R. Leurs,et al.  Identification of rat H3 receptor isoforms with different brain expression and signaling properties. , 2001, Molecular pharmacology.

[214]  T. Watanabe,et al.  Role of histamine H(1) receptor in pain perception: a study of the receptor gene knockout mice. , 2000, European journal of pharmacology.

[215]  J. Palacios,et al.  Distribution of the histamine H(2) receptor in monkey brain and its mRNA localization in monkey and human brain. , 2000, Synapse.

[216]  J. García-Rafanell,et al.  Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). , 1997, The Journal of pharmacology and experimental therapeutics.

[217]  S. Hill,et al.  Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. , 1996, European journal of pharmacology.

[218]  R. Leurs,et al.  Molecular pharmacological aspects of histamine receptors. , 1995, Pharmacology & therapeutics.

[219]  R. González,et al.  Histamine H1 receptor binding sites in mouse uterine horns. , 1993, General pharmacology.

[220]  J. Schwartz,et al.  Histaminergic transmission in the mammalian brain. , 1991, Physiological reviews.

[221]  D. Morton.  Pharmacology and toxicology of nizatidine. , 1987, Scandinavian journal of gastroenterology. Supplement.

[222]  T. Kuno,et al.  Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay. , 1987, Japanese journal of pharmacology.

[223]  J. Abita,et al.  Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP. , 1982, Molecular pharmacology.

[224]  J. C. Emmett,et al.  Characterization and development of cimetidine as a histamine H2-receptor antagonist. , 1978, Gastroenterology.

[225]  J. McNeill,et al.  Histamine2 receptors in rat uterus. , 1975, Research communications in chemical pathology and pharmacology.